article Open AccessTop 10% cited
Structure–activity relationship study of bone morphogenetic protein (BMP) signaling inhibitors
Bioorganic & Medicinal Chemistry Letters · 2008 · Vol. 18(15) · pp. 4388–4392
Gregory D. Cuny✉(Harvard NeuroDiscovery Center)Paul B. Yu(Massachusetts General Hospital)Joydev K. Laha(Brigham and Women's Hospital)Xuechao Xing(Harvard University)Jifeng LiuCarol Lai(Massachusetts General Hospital)Donna Y. Deng(Harvard University)Chetana Sachidanandan(Harvard University)Kenneth D. Bloch(Harvard University)Randall T. Peterson(Massachusetts General Hospital)
TGF-β signaling in diseasesParathyroid Disorders and TreatmentsHeterotopic Ossification and Related ConditionsChemistryBone morphogenetic proteinPyrimidinePiperazineSMADPhosphorylationIn vivoBone morphogenetic protein 2QuinolineStereochemistry
MeSH terms
AnimalsFemaleMalePiperazinesPyrazolesPyrimidinesStructure-Activity RelationshipMolecular StructureSignal TransductionBone Morphogenetic ProteinsCombinatorial Chemistry TechniquesMiceBone Morphogenetic Protein Receptors
Funding
- Harvard NeuroDiscovery Center
- Pulmonary Hypertension Association
- GlaxoSmithKline
- National Institutes of Health
Citations
337
FWCI
5.24
field-weighted impact
References
36
Percentile
96%
vs. same field & year
Citations per year
References
Role of AMP-activated protein kinase in mechanism of metformin action
Journal of Clinical Investigation · 2001 · 5,364 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.